Avant Diagnostics, Inc. (OTCQB: AVDX) is a medical diagnostic technology company that specializes in large panel biomarker screening. The company is seeking FDA approval of a test for early detection for pre-symptomatic ovarian cancer.

Biotechnology

Avant Diagnostics

Mick Ruxin

Mike Vallone

Claudius Mueller

Mattia Cremona

Trevor McCartney

The Advisory Board at Avant Diagnostics provides strategic guidance and expert insight to support the company's mission of advancing medical diagnostic technology. Comprised of medical and scientific experts, the board focuses on enhancing the development and FDA approval process of Avant's early detection test for pre-symptomatic ovarian cancer.

Advisory Board

About

Team members

Other teams at Avant Diagnostics

Leadership Team